In our latest case study @RHAPSEDA develops a proprietary strain of E.coli which can be used to make an affordable + sustainable Strep A vaccine -
moves the company towards commercialisation & takes a step towards guaranteeing affordable vaccines for all💉
https://t.co/6zvIjrPJQT
@WHO updates list of #AMR drug-resistant bacteria most threatening to human health. Macrolide-resistant #StrepA and penicillin-resistant #StrepB are newly added. #vaccines will reduce the spread and burden of disease caused by #AMR pathogens! #glycotime
With #StrepA vaccine candidates entering the clinic, now is the time to critically engage industry partners
At @vaccinenation, Strep A Vaccine Global Consortium (#SAVAC) held a forum to help navigate barriers to investment in Strep A vaccines and how to enable next steps
Fantastic evening at the @ScotLifeScience awards hosted by @Jo_Caulfield who did not shy from highlighting our team members shiny head ;) congratulations to all winners and finalists!
A great evening celebrating Scotland’s Life Sciences Achievements! Tremendous thanks to the incredible team at @UoDLifeSciences supporting us - and celebrating being finalist with a great community! @LuigiManfrediIT and TayTherapeutics @RHAPSEDA#glycotime#strepA
@CGTCatapult thanks for organising the ATMP and vaccine network launch event: Scotland’s Innovation Landscape - looking forward to the next meeting in the coming months! @ScotEntNews and @EdinUni_IRR thanks for hosting!
We officially announced SAVAC 2.0 ahead of #RHDCongress, gathering global stakeholders working to develop safe, effective, and affordable #StrepAvaccines
Left untreated in childhood, Strep A infections can lead to rheumatic heart disease, causing heart failure later in life.
Excellent talk by @SowmyaCastro from our lab at the @BactiVac meeting on our progress towards recombinant #StrepA vaccine development. Great meeting to discuss science with new and old colleagues!
The Strep A Vaccine Global Consortium (SAVAC) is inviting proposals from interested sites in LMICs for epidemiological and field-based health economic studies while preparing for future clinical trials with #StrepA vaccine candidates
Learn more and share: https://t.co/OQeDTslS0w
JOB ALERT: Are you curious about bacterial virulence factors & have experience in structural biology/CryoEM/TEM? #strepA#glycotime Join us as postdoc on an exciting journey in sunny Dundee, Scotland @UoDLifeSciences - informal inquires welcome https://t.co/WHWWqEVNgv
Medical professionals observed higher rates of Strep A infections than usual last winter, so we decided to write an article reminding everyone about the symptoms and treatment - here it is again in case you missed it the first time around - please read:
https://t.co/L7PuTfzISq
A new @UoDLifeSciences spinout opportunity - @RHAPSEDA - hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics
https://t.co/FobJjE9nEQ